Department of Health, Department of Business, Energy and Industrial Strategy 2 November 2017
- A joint response to the Accelerated Access Review, setting out how government will improve patient access to breakthrough technologies and treatments.
- Key elements include:
- an Accelerated Access Collaborative that will develop an accelerated access pathway to bring breakthrough products to market and then to patients as quickly as possible
- £86 million government funding to support innovators and the NHS in overcoming barriers to getting new, innovative technologies to patients quickly
- improved NHS England commercial capacity and capability to deliver deals that achieve better value for the NHS and innovators.
